Company Filing History:
Years Active: 2009
Title: Inventor Akinobu Nakanishi: Pioneering Innovations in Medicine
Introduction
Akinobu Nakanishi is a renowned inventor based in Tokyo, Japan, with a significant contribution to the field of medicine through his innovative creations. With a total of three patents to his name, Nakanishi has focused his efforts on developing treatments for diseases affected by CCR3, highlighting his commitment to improving healthcare outcomes.
Latest Patents
Nakanishi's most recent patents include a groundbreaking cyclic amine CCR3 antagonist. This invention comprises a medicine that features a cyclic amine derivative as an active ingredient, along with pharmaceutically acceptable acid addition salts or C-to-C alkyl addition salts. This innovative medicine is designed to treat or prevent conditions associated with CCR3, including asthma and allergic rhinitis.
Another notable patent is related to 4,4-disubstituted piperidine derivatives exhibiting CCR3 antagonism. This invention introduces low molecular weight compounds capable of inhibiting the binding of CCR3 ligands to CCR3 receptors on target cells. The patent outlines various 4,4-(disubstituted)piperidine derivatives, their pharmaceutically acceptable acid adducts, and C-Calkyl adducts. These compounds aim to provide effective treatments for diseases linked to CCR3, such as asthma and allergic rhinitis.
Career Highlights
Akinobu Nakanishi has made significant strides in his career as an inventor, working with Teijin Limited, a prominent company known for its advancements in various sectors, particularly in healthcare and pharmaceuticals. Through his work, he demonstrates a keen ability to merge scientific research with practical applications, thus enhancing the landscape of medical treatments available today.
Collaborations
Throughout his innovative journey, Nakanishi has collaborated with notable colleagues including Tomonori Yokoyama and Yoshiyuki Matsumoto. This collaborative effort fosters an environment of shared expertise and creativity, enabling the development of cutting-edge solutions in the medical field.
Conclusion
Akinobu Nakanishi stands out as a visionary inventor whose work in developing CCR3 antagonists significantly contributes to medical advancements. His dedication to innovation not only showcases his inventive spirit but also emphasizes the critical role of collaboration in achieving breakthroughs that can positively impact lives affected by respiratory conditions. As he continues to lead in his field, the potential for future discoveries remains promising.